The evolving threat of antibiotic resistance in Europe: New data from the Alexander Project

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue TOPIC T1, 2000, Pages 3-9

  Schito, G C ^a   Debbia, E A ^a   Marchese, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFOTAXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; LORACARBEF; MACROLIDE; OFLOXACIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; COMMUNITY; CONTROLLED STUDY; ENZYME SYNTHESIS; EUROPE; FRANCE; HAEMOPHILUS INFLUENZAE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; PENICILLIN RESISTANCE; PHENOTYPE; PREVALENCE; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 0033910922     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jac.a020891     Document Type: Article

References (17)

1. Mandell, L. A. (1995). Community-acquired pneumonia: etiology, epidemiology and treatment. Chest 108, 35S-42S.
2. Ball, P. (1995). Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 108, 43S-52S.
3. Goldstein, F., Bryskier, A., Appelbaum, P. C., Bauernfeind, A., Jacobs, M., Schito, G. C. et al. (1998). The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral bacterial agents against respiratory pathogens. Clinical Microbiology and Infection 4, Suppl. 2, S8-18.
4. Felmingham, D. (1995). Antibiotic resistance: do we need new therapeutic approaches? Chest 108, 70S-78S.
5. Bartlett, J. G., Breiman, R. F. & Mandell, L. A. (1998). Community-acquired pneumonia in adults: guidelines for management. Clinical Infectious Diseases 26, 811-38.
6. Klugman, K. P. & Feldman, C. (1999). Penicillin and cephalosporin-resistant Streptococcus pneumoniae - emerging treatment for an emerging problem. Drugs 58, 1-4.
7. Felmingham, D. & Grüneberg, R. N. (1996). A multicenter collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 1-57.
8. Grüneberg, R. N., Felmingham, D. & the Alexander Project Group. (1996). Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired, lower respiratory tract bacterial pathogens. Diagnostic Microbiology and Infectious Disease 25, 169-81.
9. National Committee for Clinical Laboratory Standards. (1998). Performance Standards for Antimicrobial Susceptibility Testing: Eighth Informational Supplement M100-S8. NCCLS, Wayne, PA.
10. Schito, G., Mannelli, S., Cibrario-Sent, M., Pesce, A. & Marchese, A. (1999). Evoluzione delle resistenze ai farmaci antimicrobici in Streptococcus pneumoniae circolante in Italia. Analisi dei dati dell'Osservatorio Epidemiologico Italiano (1998). Giornale Italiano di Microbiologia Medica Odontoiatrica e Clinica 3, 11-88.
11. Felmingham, D. & Washington, J. (1999). Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens -findings of the Alexander Project 1992-1996. Journal of Chemotherapy 11, Suppl. 1, 5-21.
12. Goldstein, F. W. & Acar, J. F. (1996). Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae - results of a 1992-1993 Western European and United States collaborative surveillance study. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 71-84.
13. Goldsmith, C. E., Moore, J. E. & Murphy, P. G. (1997). Pneumococcal resistance in the UK. Journal of Antimicrobial Chemotherapy 40, Suppl. A, 11-8
14. Clairoux, N., Picard, M., Brochu, A., Rousseau, N., Gourde, P., Beauchamp, D. et al. (1992). Molecular basis of the non-β-lactamase-mediated resistance to β-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Antimicrobial Agents and Chemotherapy 36, 1504-13.
15. Jacobs, M. R., Bajaksouzian, S., Lin, G. & Appelbaum, P. C. (1988). Susceptibility ot Streptococcus pneumoniae and Haemophilus influenzae to oral agents. Results of a 1997 epidemiologic study. In Program and Abstracts of the Ninety-Eighth General Meeting of the American Society of Microbiologists, Atlanta, GA, 12-17 May. Abstract A31. American Society for Microbiology, Washington, DC.
16. Catlin, B. W. (1990). Branhamella catarrhalis, an organism gaining respect as a pathogen. Clinical Microbiology Reviews 3, 293-320.
17. Jorgensen, J. H., Doern, G. V., Maher, L. A., Howell, A. W. & Redding, J. S. (1990). Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy 34, 2075-80.